In summary, CREB3 is identified as a suppressor of HCC progression in vitro and in vivo, which attributed to decreasing the phosphorylation of AKT by interfering interaction of INSR with IRS1 and transcriptionally activating RBM38. This evidence concerns the gene AKT1 and hepatocellular carcinoma.